human
respiratori
syncyti
viru
rsv
common
viral
pathogen
caus
lower
respiratori
tract
infect
infant
children
global
studi
develop
duplex
revers
transcript
recombinaseaid
amplif
duplexrtraa
assay
contain
intern
control
singl
close
tube
detect
human
rsv
intern
control
amplif
effect
elimin
falseneg
result
ensur
accuraci
duplexrtraa
system
first
develop
evalu
univers
singleplexrtraa
assay
rsv
sensit
assay
rsv
determin
copi
per
reaction
specif
next
duplexrtraa
assay
intern
control
establish
sensit
duplexrtraa
assay
approach
copi
per
reaction
crossreact
common
respiratori
virus
observ
two
detect
method
singleplexrtraa
duplexrtraa
develop
studi
use
test
clinic
specimen
result
show
absolut
consist
rsv
rtqpcr
analysi
demonstr
diagnost
sensit
specif
data
indic
duplexrtraa
great
potenti
rapid
detect
rsv
high
sensit
acut
respiratori
tract
infect
arti
one
main
caus
outpati
visit
hospit
death
especi
children
elderli
immunocompromis
individu
major
pathogen
caus
arti
infant
young
children
virus
frequent
report
includ
respiratori
syncyti
viru
rsv
adenoviru
influenza
virus
b
rhinoviru
parainfluenza
viru
research
indic
pneumonia
bronchiti
infant
frequent
caus
rsv
pathogen
microorgan
area
rsv
envelop
viru
belong
famili
paramyxovirida
singlestrand
nonseg
negativesens
rna
two
distinct
group
b
rsv
distinguish
antigen
genet
variat
respiratori
infect
rsv
may
lead
bronchiti
bronchial
pneumonia
sever
pneumonia
even
lifethreaten
rsv
pneumonia
difficult
distinguish
pneumonia
caus
influenza
viru
adenoviru
base
clinic
symptom
current
still
effect
vaccin
treatment
therefor
rapid
accur
detect
rsv
great
import
monitor
control
preval
rsv
also
provid
reliabl
laboratori
evid
earli
clinic
diagnosi
select
appropri
treatment
convent
laboratori
diagnosi
rsv
infect
involv
use
cell
cultur
direct
immunofluoresc
assay
dfa
rapid
antigen
detect
test
radt
revers
transcript
polymeras
chain
reaction
rtpcr
realtim
rtpcr
multiplex
rtpcr
although
cell
cultur
consid
gold
standard
viru
detect
high
specif
low
sensit
time
requir
limit
applic
clinic
diagnosi
serolog
detect
also
disadvantag
low
sensit
recent
year
rtpcr
high
sensit
specif
gradual
becom
mainstream
method
pathogen
detect
howev
rtpcr
requir
special
technic
expertis
dedic
laboratori
expens
thermocycl
equip
also
timeconsum
costli
conduc
widespread
use
convent
laboratori
lowresourc
area
isotherm
amplif
techniqu
develop
recent
year
provid
altern
pcr
technolog
exampl
isotherm
nucleic
acid
amplif
techniqu
includ
nucleicacidsequencebas
amplif
nasba
loopmedi
isotherm
amplif
lamp
helicasedepend
amplif
hda
recombinas
polymeras
amplif
rpa
recombinaseaid
amplif
raa
method
requir
thermocycl
unlik
isotherm
amplif
techniqu
raa
requir
initi
denatur
step
separ
doublestrand
dna
basic
raa
assay
includ
two
specif
primer
three
core
protein
recombinas
uvsx
escherichia
coli
dna
polymeras
singlestrand
dna
bind
protein
ssb
reaction
carri
within
minut
realtim
raa
reaction
system
addit
includ
novel
exo
oligonucleotid
probe
exonucleas
iii
addit
basic
system
studi
develop
duplexrtraa
assay
detect
rsv
competit
intern
control
specif
sensit
clinic
perform
assay
evalu
total
clinic
specimen
nasopharyng
secret
collect
hospit
patient
acut
viral
infect
lower
respiratori
tract
children
hospit
hebei
provinc
china
januari
march
patient
femal
male
age
rang
month
year
studi
specimen
test
retrospect
use
gexpbas
multiplex
rtpcr
assay
method
establish
previous
laboratori
posit
rsv
posit
respiratori
virus
neg
viral
rna
extract
use
viral
rnadna
isol
kit
tianlong
suzhou
china
accord
manufactur
instruct
extract
elut
elut
buffer
store
process
studi
conduct
approv
institut
review
board
nation
institut
viral
diseas
control
prevent
center
diseas
control
prevent
china
caregiv
children
inform
sign
written
inform
consent
download
avail
complet
genom
sequenc
rsv
nation
center
biotechnolog
inform
databas
ncbi
perform
multipl
sequenc
align
use
vector
nti
version
identifi
genom
region
highli
conserv
genotyp
rsv
design
univers
primer
probe
rsv
primer
rsvf
rsvr
rsv
probe
target
lgene
region
rsv
use
followup
studi
rsv
intern
control
rsvic
probe
pic
also
design
target
intern
control
ic
templat
rsv
duplex
raa
assay
oligonucleotid
use
studi
list
tabl
rsv
probe
rsvic
probe
label
fam
hex
fluorophor
respect
primer
probe
design
aid
nonspecif
sequenc
found
oligonucleotid
purifi
hplc
synthes
sangon
biotech
shanghai
china
rtpcr
primer
tabl
use
amplifi
rsv
plasmid
design
studi
use
amplifi
fragment
rsv
genom
extend
nt
nt
genbank
access
verifi
sanger
sequenc
clone
vector
tsingk
biotech
corp
beij
china
intern
control
ic
templat
sequenc
recombin
sequenc
consist
two
fragment
rose
rosett
viru
nt
genbank
access
rsv
nt
genbank
access
rsv
fragment
contain
common
primer
sequenc
sequenc
serv
backbon
probebind
region
rsv
replac
rose
rosett
viru
fragment
thu
ic
sequenc
contain
primer
templat
sequenc
target
rsv
plasmid
probebind
region
differ
fig
recombin
plasmid
contain
ic
sequenc
rsvic
construct
tsingk
biotech
corp
beij
china
synthes
ic
region
clone
vector
plasmid
dna
quantifi
use
qubit
dsdna
brhr
assay
kit
qubit
fluoromet
life
technolog
warrington
uk
accord
manufactur
instruct
rsv
recombin
plasmid
standard
serial
dilut
rsvic
plasmid
serial
dilut
univers
singleplexrtraa
assay
perform
reaction
volum
use
rtraa
exo
kit
qitian
jiangsu
china
accord
manufactur
instruct
briefli
rehydr
buffer
dnasefre
water
primer
probe
ad
rtraa
tube
contain
dri
enzym
pellet
ssb
uvsx
dna
polymeras
exonucleas
iii
cover
tube
mix
content
tap
lightli
brief
centrifug
mm
magnesium
acet
rna
templat
dnasefre
water
notempl
control
ntc
ad
tube
reaction
mix
incub
constanttemperatur
oscil
mix
instrument
qitian
jiangsu
china
minut
transfer
fluoresc
detect
instrument
fam
hex
dual
channel
detect
equip
qitian
jiangsu
china
min
ntc
reaction
perform
parallel
base
singleplexrtraa
assay
tri
duplexrtraa
assay
introduc
intern
control
duplexrtraa
assay
also
perform
reaction
volum
use
rt
exo
kit
qitian
jiangsu
china
reaction
mixtur
contain
dri
enzym
pellet
ssb
uvsx
dna
polymeras
exonucleas
iii
rehydr
buffer
dnasefre
water
primer
probe
rsvic
probe
rsvic
plasmid
copi
per
reaction
remain
reaction
compon
includ
rna
templat
dnasefre
water
ntc
mm
magnesium
acet
reaction
condit
procedur
singleplexrtraa
assay
reaction
describ
concentr
rsvic
plasmid
optim
ensur
amplif
rsvic
would
affect
amplif
rsv
templat
amplif
signal
could
detect
dilut
rsv
plasmid
use
seri
dilut
rsv
plasmid
copi
per
reaction
determin
optim
concentr
rsvic
duplexrtraa
assay
repeat
eight
time
ntc
reaction
perform
run
describ
previous
sensit
singleplexrtraa
assay
duplexrtraa
assay
evalu
use
serial
tenfold
dilut
rsv
recombin
plasmid
standard
rsvneg
clinic
specimen
use
evalu
specif
sampl
posit
one
follow
pathogen
adenoviru
adv
influenza
viru
b
flua
b
human
rhinoviru
hrv
parainfluenza
viru
piv
coronaviru
cov
human
metapneumoviru
hmpv
human
bocaviru
hbov
assay
repeat
eight
time
ttg
ggt
tgt
taa
cat
aga
studi
pcrr
tca
ttg
gtt
gtc
aag
ctg
ttt
rtraa
rsvf
tcc
yaa
ttg
tat
agc
att
cat
agg
tga
agg
agc
studi
rsvr
ttg
cat
ctg
tag
cag
gaa
tgg
tya
aat
tyt
cac
total
clinic
specimen
nasopharyng
secret
test
singleplexrtraa
duplexrtraa
method
result
compar
obtain
use
previous
report
rtqpcr
method
dilut
rang
copi
per
reaction
rsv
recombin
plasmid
standard
use
determin
analyt
sensit
singleplexrtraa
assay
reproduc
assay
evalu
test
dilut
eight
time
reaction
copi
templat
success
detect
dilut
one
copi
templat
detect
six
time
data
shown
tabl
signal
ntc
reaction
typic
sensit
amplif
curv
assay
rsv
shown
fig
seventyseven
clinic
specimen
patient
respiratori
viru
infect
use
evalu
specif
assay
result
show
crossreact
respiratori
virus
indic
singleplexrtraa
assay
specif
rsv
data
shown
optimum
concentr
rsvic
copi
duplexrtraa
assay
eight
replic
rsv
plasmid
rang
copi
per
reaction
show
posit
result
five
eight
reaction
copi
templat
posit
rsv
tabl
result
show
duplexrtraa
assay
abl
detect
copi
per
reaction
presenc
copi
rsvic
per
reaction
detect
limit
rsv
duplexrtraa
assay
probabl
copi
per
reaction
probit
analysi
p
amplif
curv
duplexrtraa
shown
fig
b
ntc
reaction
perform
parallel
signal
observ
clinic
evalu
singleplexrtraa
assay
duplexrtraa
assay
perform
use
clinic
specimen
nasopharyng
secret
rtqpcr
assay
perform
parallel
shown
tabl
rsv
specimen
detect
rtraa
assay
result
agreement
obtain
rtqpcr
also
show
rsvposit
specimen
ct
valu
sampl
rang
result
show
sensit
specif
rtraa
assay
consist
rtqpcr
test
clinic
sampl
ic
amplif
signal
detect
rsvposit
specimen
also
nonrsv
specimen
ntc
indic
rsvic
work
effect
kappa
valu
rtqpcr
singleplexrtraa
duplexrtraa
p
reveal
signific
differ
two
presenc
seri
concentr
rsv
plasmid
ic
copi
amplif
signal
appear
approxim
time
howev
rsv
plasmid
concentr
increas
fluoresc
intens
ic
decreas
presenc
copi
rsv
plasmid
per
reaction
signific
competit
inhibit
observ
amplif
ic
presenc
copi
rsv
plasmid
per
reaction
amplif
ic
significantli
inhibit
rtraa
assay
rtqpcr
assay
detect
rsv
cycl
threshold
ct
valu
rtqpcr
threshold
time
tt
valu
duplexrtraa
well
correl
r
valu
fig
rapid
accur
diagnosi
rsv
infect
necessari
monitor
control
rsv
epidem
clinic
set
investig
outbreak
pointofcar
test
poct
doubt
power
tool
regard
advantag
portabl
experiment
instrument
simpl
oper
realtim
report
result
duplexrtraa
assay
take
minut
obtain
posit
result
wherea
rtqrcr
usual
requir
hour
moreov
pcr
also
requir
profession
oper
special
experi
configur
thermocycl
equip
achiev
high
precis
major
obstacl
applic
field
poct
present
studi
duplexrtraa
assay
rsv
achiev
level
sensit
specif
compar
rtqpcr
characterist
rapid
portabl
instrument
labor
save
low
cost
combin
use
lyophil
reagent
conveni
storag
transport
give
duplexrtraa
assay
great
potenti
applic
field
poct
clinic
diagnosi
rsv
extent
presenc
nucleic
acid
inhibitor
limit
applic
nucleic
acid
test
nat
pcr
isotherm
amplif
technolog
significantli
reduc
sensit
amplif
effici
even
lead
fals
neg
result
turn
lead
erron
diagnosi
thu
reliabl
detect
method
critic
clinic
diagnosi
previou
studi
develop
raa
assay
detect
sever
pathogen
rsva
b
coxsackieviru
coxsackieviru
singlenucleotid
polymorph
snp
focus
detect
pathogen
success
appli
intern
control
monitor
reaction
system
sinc
raa
reaction
enzymat
reaction
control
varieti
enzym
suscept
influenc
inhibitor
specimen
differ
previou
studi
ad
ic
achiev
optim
condit
experiment
oper
monitor
possibl
inhibitori
reaction
experi
order
elimin
falseneg
result
improv
reliabl
assay
two
main
type
ic
competit
noncompetit
noncompetit
ic
requir
differ
primer
probe
reaction
due
differ
primer
sequenc
amplif
noncompetit
sequenc
may
accur
reflect
amplif
primari
target
order
avoid
risk
unnecessari
interact
multipl
primer
use
competit
ic
method
amplifi
target
ic
set
common
primer
reaction
tube
condit
case
sequenc
differ
rsv
sequenc
rsvic
sequenc
probebind
region
contrast
anoth
report
competit
ic
method
strategi
allow
raa
amplifi
target
rsvic
simultan
ensur
maximum
extent
competit
amplif
effici
normal
competit
ic
reduc
effici
amplif
target
turn
affect
sensit
detect
duplexrtraa
assay
determin
optim
concentr
ic
copi
per
reaction
concentr
stabil
duplexrtraa
assay
confirm
sensit
detect
rsv
affect
interpret
result
obtain
use
duplexrtraa
assay
follow
target
pathogen
ic
amplifi
result
regard
posit
ic
amplifi
target
pathogen
result
regard
neg
target
pathogen
amplifi
ic
result
regard
posit
result
might
due
high
concentr
target
pathogen
competit
inhibit
amplif
ic
neither
target
pathogen
ic
amplifi
result
indic
reaction
inhibit
test
result
sampl
invalid
previou
studi
shown
l
polymeras
gene
highli
conserv
among
rsv
strain
rtraa
assay
detect
rsv
also
develop
target
locu
singleplexrtraa
assay
duplexrtraa
assay
show
excel
sensit
reproduc
specif
sensit
duplexrtraa
assay
copi
per
reaction
determin
probit
analysi
result
eight
run
suffici
sensit
detect
specif
test
perform
test
clinic
specimen
contain
nonrsv
respiratori
pathogen
nonspecif
amplif
detect
found
indic
crossdetect
respiratori
virus
order
verifi
diagnost
applic
clinic
effect
method
establish
studi
clinic
specimen
nasopharyng
aspir
test
simultan
two
rtraa
assay
rtqpcr
use
refer
result
two
assay
consist
rtqpcr
indic
perform
method
satisfactori
therefor
believ
duplexrtraa
reliabl
method
identif
rsv
research
need
improv
first
specimen
studi
nasopharyng
aspir
collect
children
differ
type
specimen
still
need
test
verifi
applic
duplexrtraa
assay
second
multiplex
amplif
raa
intern
control
need
evalu
use
larger
sampl
size
summari
duplexrtraa
assay
incorpor
intern
control
success
develop
evalu
use
clinic
sampl
rapid
identif
rsv
high
sensit
specif
inclus
intern
control
provid
valuabl
refer
practic
applic
duplexrtraa
assay
expect
attract
altern
tradit
laboratorybas
molecular
diagnost
method
lowresourc
set
